International Clinical Trial: The Efficacy and Safety of Tirofiban after Intravenous Thrombolysis for Acute Branch Atherosclerosis disease:a prospective, open-label, blinded-end point, randomized controlled trial

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118396) titled 'The Efficacy and Safety of Tirofiban after Intravenous Thrombolysis for Acute Branch Atherosclerosis disease:a prospective, open-label, blinded-end point, randomized controlled trial' on Feb. 4.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Chengdu Second People's Hospital

Condition: Acute branch Atherosclerosis disease

Intervention: control group:Dual Antiplatelet Therapy (DAPT)(Aspirin + Clopidogrel)

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-02-05

Target Sample Size: control group:102;tirofiban group:102;

Countries of Recruitment: Chi...